enteric coated aspirin - does this reduce risk of bleeding complications?
Last reviewed 10/2023
- there is no evidence that using enteric coated or buffered formulations of aspirin provide less of a risk than the use of dispersible aspirin 75mg, which is an appropriate dosage form
Reference:
- MeReC Bulletin 2005; 15(6):21-4.